Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-04-02 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sale 10b5-1 −897 $46.95 $42K 75,997
2025-03-17 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −2,037 $55.24 $113K 77,365
2025-03-17 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −1,085 $56.62 $61K 76,280
2025-03-17 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −3,340 $57.67 $193K 72,940
2025-03-17 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −300 $58.31 $17K 72,640
2025-03-14 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −4,458 $55.19 $246K 79,402
2025-03-13 Okey Stephanie Director Sale −5,000 $54.00 $270K 8,867
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +13,126 $33.02 $433K 117,027
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −13,126 $53.31 $700K 103,901
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +2,395 $33.02 $79K 106,296
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −2,395 $53.23 $127K 103,901
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −13,126 0
2025-03-12 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −2,395 0
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +5,662 $33.02 $187K 109,563
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −5,662 $53.02 $300K 103,901
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +1,719 $33.02 $57K 105,620
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,719 $53.01 $91K 103,901
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −5,662 13,126
2025-03-11 Boulding Mark Elliott EXEC. VP AND CLO Option exercise · Stock Option (Right to Buy) 10b5-1 −1,719 2,395
2025-03-10 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +45,392 $33.02 $1.5M 149,293

Page 26 of 41 · 804 trades